Transparency
Batch-level verification, not generic claims
Each batch is tested by third-party Australian laboratories, assigned a unique batch identifier, and published with its corresponding Certificate of Analysis.
| Batch ID | Compound | Purity | Released |
|---|---|---|---|
| AUR-RET-2608-01 | Retatrutide | 99.79% | 12 Nov 2026 |
| AUR-RET-2607-02 | Retatrutide | 99.65% | 09 Nov 2026 |
| AUR-RET-2606-03 | Retatrutide | 99.94% | 04 Nov 2026 |
| AUR-TIR-2607-01 | Tirzepatide | 99.91% | 09 Nov 2026 |
| AUR-TIR-2606-02 | Tirzepatide | 99.57% | 04 Nov 2026 |
| AUR-TIR-2605-03 | Tirzepatide | 99.89% | 28 Oct 2026 |
| AUR-TIR-2604-04 | Tirzepatide | 99.58% | 22 Oct 2026 |
| AUR-SEM-2606-01 | Semaglutide | 99.35% | 04 Nov 2026 |
| AUR-SEM-2605-02 | Semaglutide | 99.00% | 28 Oct 2026 |
| AUR-SEM-2604-03 | Semaglutide | 99.33% | 22 Oct 2026 |
| AUR-BPC-2605-01 | BPC-157 | 99.94% | 28 Oct 2026 |
| AUR-BPC-2604-02 | BPC-157 | 99.63% | 22 Oct 2026 |
| AUR-BPC-2603-03 | BPC-157 | 99.94% | 18 Oct 2026 |
| AUR-BPC-2602-04 | BPC-157 | 99.64% | 11 Oct 2026 |
| AUR-TB5-2604-01 | TB-500 | 99.94% | 22 Oct 2026 |
| AUR-TB5-2603-02 | TB-500 | 99.45% | 18 Oct 2026 |
| AUR-TB5-2602-03 | TB-500 | 99.94% | 11 Oct 2026 |
| AUR-BPC-2603-01 | BPC-157 + TB500 | 99.05% | 18 Oct 2026 |
| AUR-BPC-2602-02 | BPC-157 + TB500 | 99.00% | 11 Oct 2026 |
| AUR-BPC-2608-03 | BPC-157 + TB500 | 99.03% | 30 Sep 2026 |
| AUR-BPC-2607-04 | BPC-157 + TB500 | 99.00% | 12 Nov 2026 |
| AUR-GHK-2602-01 | GHK-Cu | 99.94% | 11 Oct 2026 |
| AUR-GHK-2608-02 | GHK-Cu | 99.53% | 30 Sep 2026 |
| AUR-GHK-2607-03 | GHK-Cu | 99.92% | 12 Nov 2026 |
| AUR-MOT-2608-01 | MOTS-C | 99.31% | 30 Sep 2026 |
| AUR-MOT-2607-02 | MOTS-C | 99.00% | 12 Nov 2026 |
| AUR-MOT-2606-03 | MOTS-C | 99.29% | 09 Nov 2026 |
| AUR-MOT-2605-04 | MOTS-C | 99.00% | 04 Nov 2026 |
| AUR-CJC-2607-01 | CJC-1295 NO DAC + IPA | 99.44% | 12 Nov 2026 |
| AUR-CJC-2606-02 | CJC-1295 NO DAC + IPA | 99.00% | 09 Nov 2026 |
| AUR-CJC-2605-03 | CJC-1295 NO DAC + IPA | 99.42% | 04 Nov 2026 |
| AUR-IPA-2606-01 | Ipamorelin 10mg | 99.94% | 09 Nov 2026 |
| AUR-IPA-2605-02 | Ipamorelin 10mg | 99.79% | 04 Nov 2026 |
| AUR-IPA-2604-03 | Ipamorelin 10mg | 99.94% | 28 Oct 2026 |
| AUR-IPA-2603-04 | Ipamorelin 10mg | 99.80% | 22 Oct 2026 |
| AUR-TES-2605-01 | TESAMORELIN | 99.75% | 04 Nov 2026 |
| AUR-TES-2604-02 | TESAMORELIN | 99.46% | 28 Oct 2026 |
| AUR-TES-2603-03 | TESAMORELIN | 99.73% | 22 Oct 2026 |
| AUR-NAD-2604-01 | NAD+ 500mg | 99.23% | 28 Oct 2026 |
| AUR-NAD-2603-02 | NAD+ 500mg | 99.00% | 22 Oct 2026 |
| AUR-NAD-2602-03 | NAD+ 500mg | 99.21% | 18 Oct 2026 |
| AUR-NAD-2608-04 | NAD+ 500mg | 99.00% | 11 Oct 2026 |
| AUR-PT1-2603-01 | PT-141 10mg | 99.94% | 22 Oct 2026 |
| AUR-PT1-2602-02 | PT-141 10mg | 99.67% | 18 Oct 2026 |
| AUR-PT1-2608-03 | PT-141 10mg | 99.94% | 11 Oct 2026 |
| AUR-MEL-2602-01 | MELANOTAN II 10mg | 99.94% | 18 Oct 2026 |
| AUR-MEL-2608-02 | MELANOTAN II 10mg | 99.42% | 11 Oct 2026 |
| AUR-MEL-2607-03 | MELANOTAN II 10mg | 99.94% | 30 Sep 2026 |
| AUR-MEL-2606-04 | MELANOTAN II 10mg | 99.43% | 12 Nov 2026 |
| AUR-KLO-2608-01 | KLOW 80mg | 99.02% | 11 Oct 2026 |
| AUR-KLO-2607-02 | KLOW 80mg | 99.00% | 30 Sep 2026 |
| AUR-KLO-2606-03 | KLOW 80mg | 99.00% | 12 Nov 2026 |
| AUR-BAC-2607-01 | Bacteriostatic Water | 99.94% | 30 Sep 2026 |
| AUR-BAC-2606-02 | Bacteriostatic Water | 99.77% | 12 Nov 2026 |
| AUR-BAC-2605-03 | Bacteriostatic Water | 99.94% | 09 Nov 2026 |
| AUR-BAC-2604-04 | Bacteriostatic Water | 99.78% | 04 Nov 2026 |
Third-Party Tested
Every batch undergoes independent HPLC-MS analysis by accredited laboratories.
Unique Batch IDs
Each batch is assigned a unique identifier for full traceability from source to delivery.
Published COAs
Certificates of Analysis are published publicly and linked directly to each product.
Purity Verified
Results confirm identity, purity, and composition meet our 99%+ standard before release.